NO20035399L - Pyrrolidinoksadiazol- og tiadiazolderivater - Google Patents

Pyrrolidinoksadiazol- og tiadiazolderivater

Info

Publication number
NO20035399L
NO20035399L NO20035399A NO20035399A NO20035399L NO 20035399 L NO20035399 L NO 20035399L NO 20035399 A NO20035399 A NO 20035399A NO 20035399 A NO20035399 A NO 20035399A NO 20035399 L NO20035399 L NO 20035399L
Authority
NO
Norway
Prior art keywords
thiadiazole derivatives
pyrrolidine oxadiazole
oxadiazole
pyrrolidine
thiadiazole
Prior art date
Application number
NO20035399A
Other languages
English (en)
Other versions
NO20035399D0 (no
Inventor
Matthias Schwarz
Russel J Thomas
Anna Quattorpani
Patrick Page
Vincent Pomel
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20035399D0 publication Critical patent/NO20035399D0/no
Publication of NO20035399L publication Critical patent/NO20035399L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20035399A 2001-06-18 2003-12-04 Pyrrolidinoksadiazol- og tiadiazolderivater NO20035399L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (2)

Publication Number Publication Date
NO20035399D0 NO20035399D0 (no) 2003-12-04
NO20035399L true NO20035399L (no) 2004-02-17

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035399A NO20035399L (no) 2001-06-18 2003-12-04 Pyrrolidinoksadiazol- og tiadiazolderivater

Country Status (27)

Country Link
US (2) US7115639B2 (no)
EP (1) EP1444225B1 (no)
JP (1) JP4426284B2 (no)
KR (1) KR20040030678A (no)
CN (1) CN100564378C (no)
AR (1) AR036108A1 (no)
AU (1) AU2002319237B2 (no)
BG (1) BG108424A (no)
BR (1) BR0211030A (no)
CA (1) CA2449578C (no)
CZ (1) CZ20033475A3 (no)
EA (1) EA006212B1 (no)
EE (1) EE200400022A (no)
ES (1) ES2397305T3 (no)
HK (1) HK1074204A1 (no)
HR (1) HRP20031017A2 (no)
HU (1) HUP0400238A2 (no)
IL (1) IL159219A0 (no)
MX (1) MXPA03011441A (no)
MY (1) MY128890A (no)
NO (1) NO20035399L (no)
PL (1) PL367275A1 (no)
RS (1) RS99503A (no)
SK (1) SK15552003A3 (no)
UA (1) UA75145C2 (no)
WO (1) WO2002102799A2 (no)
ZA (1) ZA200309402B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211030A (pt) 2001-06-18 2004-06-22 Applied Research Systems Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole
US7557136B2 (en) * 2003-02-27 2009-07-07 Laboratoires Serono Sa Pyrrolidine derivatives as oxytocin antagonists
ES2296137T3 (es) * 2004-02-26 2008-04-16 Laboratoires Serono Sa Metodo para preparar pirrolidin-oximas.
BRPI0608604B8 (pt) 2005-05-10 2021-05-25 Incyte Corp moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
CA2634198C (en) 2005-12-20 2014-06-03 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
US20080125470A1 (en) * 2006-09-19 2008-05-29 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
PT2824100T (pt) 2008-07-08 2018-05-10 Incyte Holdings Corp 1,2,5-oxadiazoles como inibidores da indoleamina 2,3-dioxigenase
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
ES2799582T3 (es) 2013-11-08 2020-12-18 Incyte Holdings Corp Proceso para la síntesis de un inhibidor de indoleamina 2,3-dioxigenasa
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
ES2774789T3 (es) 2014-07-02 2020-07-22 ObsEva SA O-Metiloxima de (3Z,5S)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil]pirrolidin-3-ona cristalina útil en métodos de tratamiento de estados relacionados con la actividad del OT-R

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
CA2210138A1 (en) 1995-01-24 1996-08-01 Peter D. Williams Tocolytic oxytocin receptor antagonists
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
US6333344B1 (en) 1999-05-05 2001-12-25 Merck & Co. Prolines as antimicrobial agents
DK1268418T3 (da) * 2000-03-27 2006-09-25 Applied Research Systems Farmaceutisk aktive pyrrolidinderivater som Bax-inhibitorer
WO2001072705A1 (en) * 2000-03-27 2001-10-04 Applied Research Systems Ars Holding N.V. Pharmaceutically active pyrrolidine derivatives as bax inhibitors
AU2002214019B2 (en) * 2000-10-17 2007-01-25 Merck Serono Sa Pharmaceutically active sulfanilide derivatives
CA2440002A1 (en) * 2001-03-20 2002-09-26 Applied Research Systems Ars Holding N.V. Pyrrolidine ester derivatives with oxytocin modulating activity
BR0211030A (pt) 2001-06-18 2004-06-22 Applied Research Systems Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole
US7468385B2 (en) * 2001-12-20 2008-12-23 Laboratoires Serono Sa Triazoles as oxytocin antagonists
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
US7115639B2 (en) 2006-10-03
EP1444225B1 (en) 2012-10-10
MXPA03011441A (es) 2004-07-01
CN1639155A (zh) 2005-07-13
EE200400022A (et) 2004-04-15
CA2449578A1 (en) 2002-12-27
US20040220238A1 (en) 2004-11-04
MY128890A (en) 2007-02-28
WO2002102799A3 (en) 2003-04-03
KR20040030678A (ko) 2004-04-09
UA75145C2 (en) 2006-03-15
JP2004534804A (ja) 2004-11-18
WO2002102799A2 (en) 2002-12-27
BR0211030A (pt) 2004-06-22
BG108424A (en) 2005-03-31
JP4426284B2 (ja) 2010-03-03
CN100564378C (zh) 2009-12-02
ES2397305T3 (es) 2013-03-06
NO20035399D0 (no) 2003-12-04
AR036108A1 (es) 2004-08-11
ZA200309402B (en) 2004-12-03
US20060229343A1 (en) 2006-10-12
RS99503A (en) 2006-12-15
CZ20033475A3 (en) 2004-05-12
PL367275A1 (en) 2005-02-21
SK15552003A3 (sk) 2004-05-04
HUP0400238A2 (hu) 2004-07-28
EP1444225A2 (en) 2004-08-11
HRP20031017A2 (en) 2004-04-30
AU2002319237B2 (en) 2008-01-03
EA200400049A1 (ru) 2004-08-26
HK1074204A1 (en) 2005-11-04
CA2449578C (en) 2011-12-13
IL159219A0 (en) 2004-06-01
EA006212B1 (ru) 2005-10-27

Similar Documents

Publication Publication Date Title
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
CY2016002I1 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
ATE319451T1 (de) Tetrahydrochinolin-derivate
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
AR028343A1 (es) Derivados de pirrolidina y piperidina
IS6759A (is) Ný þíadíasól og oxadíasól og notkun þeirra sem fosfórdíesterasa-7 hindra
HK1074204A1 (en) Pyrrolidine oxadiazole-and thiadiazole derivatives
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE297920T1 (de) Linezolid-krystall form ii
DK1226131T3 (da) Isoxazolcarboxamidderivater
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
NO20023675L (no) Heterocykliske amidderivater
DE60106740D1 (de) Hydrazid und alkoxyamid angiogeneseinhibitoren